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Signal regulatory protein a (SIRPa) and its cognate ligand CD47 have been documented
to have a broad range of cellular functions in development and immunity. Here,
we investigated the role of SIRPa–CD47 signalling in invariant NKT (iNKT) cell responses.
We found that CD47 was required for the optimal production of IFN-c from splenic
iNKT cells following exposure to the aGalCer analogue PBS-57 and in vivo infection of
mice with Leishmania donovani. Surprisingly, although SIRPa was undetectable in the
liver of uninfected mice, the hepatic iNKT-cell response to infection was also impaired
in CD47
/ mice. However, we found that SIRPa was rapidly induced on Kupffer
cells following L. donovani infection, via a mechanism involving G-protein-coupled
receptors. Thus, we describe a novel ampliﬁcation pathway affecting cytokine production
by hepatic iNKT cells, which may facilitate the breakdown of hepatic tolerance after
infection.
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Introduction
Signal regulatory protein a (SIRPa, CD172a), also known as Src
homology 2 domain-containing phosphatase substrate 1, p84
protein, brain Ig-like molecule with tyrosine based activation
motifs, macrophage fusion receptor and Myd-1 [1], has multiple
functions in immunity and development, linked to its restricted
cellular distribution [2, 3]. The most comprehensive description
of the distribution of SIRPa is in the rat, where expression was
shown on neurons, monocytes, granulocytes, tissue macrophages
and DC [2]. In immunity, SIRPa impacts on allogeneic MLR [4],
DC maturation and cytokine production [5, 6], the activation of
memory T cells [7], macrophage cytokine production [8, 9] and
macrophage fusion [10].
CD47 (also known as integrin-associated protein (IAP)) is the
only identiﬁed cellular receptor for SIRPa [ 1 1 ] .I nc o n t r a s tt ot h e
monogamous binding of SIRPa to CD47, CD47 also binds throm-
bospondin [12, 13]. In vitro CD47 can co-stimulate T cells [14, 15],
and the effects of CD47 deﬁciency on human neutrophil transmi-
gration are readily apparent [16] and are similarly observed in
rodent models of peritonitis [17], Staphylococcus aureus induced
arthritis [18] and Escherichia coli pneumonia [19]. CD47 was
recently shown to be a key signal in the development of Th17-
mediated experimental colitis via interactions with SIRPa on
CD103
 DC [20], and has shown experimental potential as an
immunotherapeutic target for adult leukaemia [21, 22].
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roles in cancer and infectious disease (for review see [23]). In the
spleen, DC are crucial for presenting CD1d-restricted ligands to
iNKT cells, whereas in the liver, Kupffer cells (KC) [24] and Ito
cells [25] perform this function. Although studies on the long-
term outcome of Leishmania donovani infection suggest that NKT
cells may ultimately be redundant in terms of regulating disease
progression [26], we have nevertheless previously shown that
hepatic iNKT-cell-derived IFN-g is essential for sustained CXCL10
responses following L. donovani infection [27]. As Src homology
2 domain-containing phosphatase substrate 1-mutant mice have
an impaired ability to clear transferred tumour cells, and lower
levels of iNKT-cell cytokine production [28], and as a role for
SIRPa–CD47 signalling in iNKT-cell responses to infection has yet
to be established, we sought to determine whether this pathway
might be involved in regulating early iNKT-cell responses to
L. donovani. Here, we show regulated expression of SIRPa on KC
following L. donovani infection and propose that SIRPa–CD47
interactions regulate the activation threshold for iNKT cytokine
production.
Results and discussion
CD47 regulates iNKT-cell activation
As anticipated [28], PBS-57-loaded CD1d tetramer
1CD3
1
cells in the spleen and liver of C57BL/6 mice expressed
CD47, whereas no detectable staining was observed in CD47
/
mice (Fig. 1A–F). iNKT cells were present at a higher frequency in
the spleen, but not the liver of CD47
/ mice when compared
with WT controls (Fig. 1G and H). In vitro stimulation of
splenocytes from CD47
/ and C57BL/6 mice with PBS-57,
an analogue of aGal-Cer [29], demonstrated that CD47
was required for optimal production of IFN-g by iNKT cells,
measured as percentage of responding cells or as integrated MFI
(iMFI) [30]( (Fig. 1I and data not shown). Similarly, injection of
PBS-57 stimulated a greater IFN-g response in WT mice
compared with CD47
/ mice (Fig. 1J). Therefore, CD47 is
required for optimal production of IFN-g by iNKT cells in the
spleen, where myeloid cells express the CD47 ligand SIRPa
constitutively at high levels [2].
CD47 co-stimulates IFN-c production by iNKT cells
after L. donovani infection
L. donovani infection results in iNKT-cell activation and IFN-g
production [26, 31]. To determine whether CD47 also co-
stimulated this response, we examined infected WT and
CD47
/ mice (Fig. 2). The percentage of splenic tetramer
1
TCR-b
1 cells that produced IFN-g (Fig. 2A and B) and the total
functional IFN-g response (Fig. 2A and C) was signiﬁcantly
reduced in infected CD47
/ mice compared with the WT mice.
Reduced detection of IFN-g-producing cells did not reﬂect
enhanced internalisation of TCR in CD47
/ mice, as similar
results were obtained on staining for surface or surface and
intracellular TCR (Supporting Information Fig. 1). There was also
a reduction in the frequency of splenic iNKT cells after infection
(Fig. 2D). CD69 expression in both WT and CD47
/ mice
was, however, increased to a similar extent (from an MFI
of 44.575.6 to 68.4722, and 42.575.4 to 70.6718.6 in WT
and CD47
/ mice, respectively), suggesting similar levels of
activation as assessed by this parameter. The expression of
CD47 on iNKT cells was unaltered at 16h post-infection (p.i.)
compared with levels seen in uninfected mice (data not shown
and Fig. 1).
If, as suggested by the above data, SIRPa–CD47 interactions
play a role in iNKT-cell activation, tissue-speciﬁc expression of
SIRPa might dictate the extent to which this co-stimulatory
pathway operates. We therefore examined responses in the liver,
where SIRPa expression is reported as low or absent [2].
Surprisingly, IFN-g production by hepatic iNKT cells was also
signiﬁcantly impaired in CD47
/ mice compared with WT mice
(Fig. 2E–G). As in the spleen, the frequency of hepatic iNKT cells
was reduced in infected CD47
/ mice (Fig. 2H). In contrast to
the spleen, however, increased expression of CD69 was limited to
iNKT cells in WT mice (from an MFI of 48.177.08 to
65.6712.95) and was not observed on hepatic iNKT cells in
CD47
/ mice (MFI of 51.6875.52 to 58.6777.15). These
data suggest that CD47 signalling variably affects different
parameters of iNKT-cell activation in a tissue-speciﬁc manner,
with a greater overall dependency on SIRPa–CD47 for hepatic
responses.
To determine whether the reduced IFN-g response of
CD47
/ mice was functionally relevant, we measured the
accumulation of CXCL10 mRNA, previously shown to be depen-
dent upon iNKT-cell-derived IFN-g [27]. L. donovani infection
resulted in a rapid accumulation of CXCL10 mRNA in WT but not
in CD47
/ mice (Fig. 2I). The reduction in IFN-g arising from
CD47-deﬁciency, therefore, has measurable down-stream effects
on the host response to infection.
L. donovani induces SIRPa expression on KC
As SIRPa is the only identiﬁed cellular receptor for CD47, yet we
detected an impaired hepatic response in CD47
/ mice, we
examined expression of SIRPa before and after L. donovani
infection. Similar to that reported in the rat [2], SIRPa was
undetectable on KC in naive mice, but was rapidly induced
following infection (Fig. 3A). SIRPa mRNA accumulation also
increased following infection, signiﬁcantly so by 5h p.i. (po0.05
comparing DCT (CT, cycle threshold) values to naı ¨ve mice;
Fig. 3B). Of all F4/80
1 KC, 8071% with clearly visible
intracellular amastigotes (AM) were SIRPa
1, whereas 6073%
of SIRPa
1 cells had identiﬁable AM, suggesting that SIRPa was
also induced in trans on uninfected KC. Infected SIRPa
1 cells
were not labelled with CD11b, a marker of inﬂammatory
monocytes and neutrophils (data not shown).
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SIRPa expression was similarly induced on KC in infected
BALB.SCID and B6.RAG1
/ mice and in B6.IFN-g
/ and B6.
IL-12p40
/ mice (data not shown), suggesting that neither
T cells, B cells nor iNKT cells, nor these key pro-inﬂammatory
cytokines were required for SIRPa induction. Parasite viability
was not an important factor, as injection of heat killed L. dono-
vani also induced SIRPa (data not shown). To address whether
other signals could induce SIRPa, we injected mice with (i) latex
beads, to reﬂect the consequences of phagocytosis per se;
(ii) zymosan, to reﬂect phagocytosis coupled with stimulation
through TLR2 and TLR6 [32] and (iii) Poly I:C, as a soluble TLR3
agonist that induces Type I IFN responses [33]). None of these
stimuli induced SIRPa expression (data not shown). As L. dono-
vani infection stimulates a rapid T-cell-independent expression of
CCL2, CCL3 and CXCL10 [34], and our data suggested that
regulation of SIRPa could occur in trans, we used pertussis
toxin (PTx) to block G-protein-coupled signalling. Administration
of PTx inhibited SIRPa induction by approximately 85%
(Fig. 3C), suggesting that G-protein signalling was indeed an
essential pre-requisite for the induction of SIRPa following
L. donovani infection.
Concluding remarks
Collectively, these data provide the ﬁrst demonstration
of pathogen-associated induction of SIRPa on KC in vivo.
Our data suggest a model whereby SIRPa on KC is regulated
by autocrine or paracrine responses to chemokines released
upon infection. In turn, we propose that induction of SIRPa
regulates optimal activation of iNKT cells by engagement of
CD47 (Fig. 3D) and thus indirectly affects the down-stream
progression of the inﬂammatory response. IL-12 has also
been shown to facilitate activation of iNKT cells in conjunc-
tion with TLR9 signalling [35] and TLR9-dependent IL-12
production by DC has also been noted following infection
with L. infantum [36]. However, as SIRPa–CD47 signalling
Figure 1. Phenotype, frequency and responsiveness of iNKT cells from CD47
/ mice. (A–F) Expression of CD47 on iNKT cells on spleen (A–C) and
liver (D–F) iNKT cells. Similar proﬁle of CD3 and tetramer staining were obtained for CD47
/ mice. Spleen (A) and liver (D) iNKT cells were
identiﬁed by excluding autoﬂuorescent cells and then gating on PBS-57-loaded CD1d tetramer
1 CD3
1cells. Splenic (B) and hepatic (E) iNKT cells in
B6 mice express CD47, whereas splenic (C) and hepatic (F) iNKT cells in CD47
/ do not. Dotted lines represent isotype controls. (G–H) The
percentage7SEM of tetramer
1 cells in the spleen (G) and liver (H) of naı ¨ve B6 and CD47
/ mice. (n520 individual mice from three independent
experiments.) (I) IFN-g production by splenic tetramer
1 TCR-b
1 cells after 16h in vitro stimulation with PBS-57; C57BL/6 (closed circles) and CD47
/
mice (open squares). Data represent mean7SEM of triplicate samples pooled from three to ﬁve mice and are representative of three independent
experiments. (J) IFN-g production by splenic tetramer
1 TCR-b
1 iNKT cells 16h after i.v. injection of 10ng PBS-57. Data represent mean7SEM (n58
mice from two independent experiments). p o 0.01, p o 0.0001, Mann–Whitney U test.
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of DC IL-12 per se is unlikely to account for the defective
iNKT-cell activation we have observed in CD47
/ mice. Further
studies will be required to ascertain the long-term impact of
disrupting SIRPa–CD47 interactions for the progression of
experimental visceral leishmaniasis, and to determine the
breadth of infections in which regulated expression of SIRPa
may similarly provide a mechanism for breaking hepatic
tolerance.
Materials and methods
Mice and parasites
BALB/c mice were obtained from Charles River (Margate, UK).
C57BL/6 (B6), BALB.SCID, B6.RAG1
/, B6.IFN-g
/, B6.IL-
12p40
/ (originally obtained from the Jackson Laboratories,
Bar Horbor, USA) and B6.CD47
/ (originating from breeding
Figure 2. IFN-g production by iNKT cells is impaired in CD47
/ mice. B6 and CD47
/ mice were infected with L. donovani i.v. 16h previously.
Representative dot plots showing IFN-g production by (A) spleen and (E) liver iNKT cells (based on tetramer/TCR-b and exclusion of
autoﬂuorescence) are shown. IFN-g responses of splenic (B and C) and hepatic (F and G) iNKT cells from naı ¨ve and infected B6 (grey bars) and
CD47
/ (open bars) mice (n512 from two independent experiments) are shown as percentage of IFN-g
1cells (corrected for isotype staining; B and
F) and as iMFI (C and G). The frequency of iNKT cells in spleen (D) and liver (H) of naı ¨ve and infected B6 (grey bars) and CD47
/ (open bars) mice.
(I) CXCL10 mRNA accumulation at 5h p.i. in B6 (grey bars) and CD47
/ (open bars) mice (n55 mice). p o 0.05, p o 0.01, p o 0.0001,
Mann–Whitney U test.
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Francisco [17]) were bred under barrier conditions at LSHTM
and the University of York Biological Services Facility. All animal
procedures were approved by institutional Animal Procedures
Ethics Committees and performed under UK Home Ofﬁce licence.
L. donovani (strain LV9) were isolated from infected hamsters
or B6.RAG1
/ mice as previously described [37]. Mice were
infected with 2–310
7 AM i.v. by the lateral tail vein. In some
experiments, an equivalent number of heat-killed AM (561C for
30min), zymosan (Sigma-Aldrich, Poole, UK) or latex beads
(3mm; Sigma-Aldrich) were injected. PTx treatment was
performed as previously described [38]. 10ng/mouse of PBS-57
(supplied by Paul Savage, Brigham Young University, Provo, UT,
USA) was injected i.v. as previously described [29].
Flow cytometry and intracellular cytokine staining
Splenic and hepatic mononuclear cells were isolated as previously
described [26, 37]. Isolated cells were incubated directly and
without further stimulation in brefeldin A (10mg/mL) for 4h. Cells
were labelled with CD16/32, NK1.1-PE, TCR-b-APC or FITC
(eBioscience, UK), CD3-PeCy7 (Biolegend, San Diego, USA) and
Alexa-488 or APC conjugated-PBS-57 loaded CD1d tetramers
(National Institutes of Health, National Institute of Allergy and
Infectious Diseases MHC Tetramer Core Facility). Labelled cells
were ﬁxed, permeabilised and labelled with Paciﬁc blue-conju-
gated IFN-g or isotype control (eBioscience). Flow cytometric
analysis was performed on a CyAn ﬂow cytometer with Summit
software (Beckman Coulter, Fullerton, USA). Autoﬂuorescent
events were excluded from analysis by gating on unused
ﬂuorescent channels. iMFI were calculated by multiplying the
frequency of IFN-g-producing cells by the MFI of the positive
population to determine the total functional IFN-g response [30].
Histological analysis of SIRPa expression
Livers from infected mice were snap frozen in isopentane,
embedded in OCT and stored at 701C until use. 6mm
cryosections were ﬁxed in acetone and labelled with rat anti-
murine p84 biotin antibody (a gift from Carl Lagenaur, University
of Pittsburgh), CD11b and F4/80 (eBioscience). AM of
L. donovani were identiﬁed using serum from L. donovani-
infected hamsters. Images were captured as 0.8–1mm optical
slices using a LSM510 confocal microscope and processed using
LSM Image Browser (Zeiss,Jera, Germany).
Real-time RT-PCR
Real-time RT-PCR was performed as previously described [37].
Oligonucleotides used for the speciﬁc ampliﬁcation of SIRPa were
CCTCACAGCAACGAAGAACA (forward) and TGGACTCATT-
CATGGTGCAG (reverse), and for ampliﬁcation of CXCL10 and
Figure 3. L. donovani induces expression of SIRPa on KC. (A) Livers
from naive B6 mice or mice infected with L. donovani 1, 2.5 or 5h
previously were stained for SIRPa (green) and L. donovani AM
(red). Images are representative of four independent experiments.
(B) Hepatic SIRPa mRNA accumulation, shown as fold increase
relative to naı ¨ve mice at timepoints indicated. (C) SIRPa expression
on KC in control and PTx-treated mice infected with L. donovani.
Data in (B) and (C) are representative of two independent
experiments. (D) Proposed model for regulation of APC–iNKT-cell
interactions through CD47-SIRPa signalling. On splenic APC,
constitutively expressed SIRPa engages CD47 and enhances the
TCR-dependent IFN-g response of iNKT cells. In the liver, SIRPa
is not constitutively expressed on KC, but expression can be
induced in response to chemokines produced as a result of L. donovani
infection.
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described previously [37]. The number of SIRPa and HPRT
cDNA molecules in each sample was calculated using QuantiTect
SYBR green master mix (QIAGEN) and an ABI Prism 7000
sequence detection system (Applied Biosystems). Accumulation
of SIRPa and Cxcl10 was normalised to HPRT and expressed as
either absolute copy number (target molecules/1000 Hprt
molecules) or relative expression via the change in cycle
threshold (DDCT) analysis method (relative expression in
infected versus naı ¨ve).
Statistical analysis
Statistical analysis was performed using two-tailed Mann–Whit-
ney U tests with 95% conﬁdence intervals.
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